<bill session="116" type="s" number="1089" updated="2022-11-01T19:32:22Z">
  <state datetime="2019-04-09">REFERRED</state>
  <status>
    <introduced datetime="2019-04-09"/>
  </status>
  <introduced datetime="2019-04-09"/>
  <titles>
    <title type="display">Restoring Access to Medication Act of 2019</title>
    <title type="short" as="introduced">Restoring Access to Medication Act of 2019</title>
    <title type="official" as="introduced">A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements.</title>
  </titles>
  <sponsor bioguide_id="R000307"/>
  <cosponsors>
    <cosponsor bioguide_id="I000055" joined="2019-04-09"/>
    <cosponsor bioguide_id="K000383" joined="2019-04-09"/>
    <cosponsor bioguide_id="M001183" joined="2019-04-09"/>
    <cosponsor bioguide_id="S001191" joined="2019-11-20"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-04-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="930" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Taxation"/>
    <term name="Health care costs and insurance"/>
    <term name="Income tax deductions"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-05-29T19:05:44Z" status="Introduced in Senate">Restoring Access to Medication Act of 2019

 This bill repeals provisions of the Internal Revenue Code, as added by the Patient Protection and Affordable Care Act, that limit payments for medications from health savings accounts, medical savings accounts, and health flexible spending arrangements to only prescription drugs or insulin (thus allowing distributions from such accounts for over-the-counter drugs).</summary>
</bill>
